Peroxisome proliferator-activated receptor α controls cellular cholesterol trafficking in macrophages

被引:58
|
作者
Chinetti-Gbaguidi, G
Rigamonti, E
Helin, L
Mutka, AL
Lepore, M
Fruchart, JC
Clavey, V
Ikonen, E
Lestavel, S
Staels, B [1 ]
机构
[1] Inst Pasteur, INSERM, UR 545, F-59019 Lille, France
[2] Univ Lille 2, Lille, France
[3] Univ Helsinki, Inst Biotechnol, Helsinki, Finland
关键词
nuclear receptors; gene regulation; atherosclerosis; cholesterol homeostasis;
D O I
10.1194/jlr.M500326-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mobilization of cholesterol from intracellular pools to the plasma membrane is a determinant that governs its availability for efflux to extracellular acceptors. NPC1 and NPC2 are proteins localized in the late endosome and control cholesterol transport from the lysosome to the plasma membrane. Here, we report that NPC1 and NPC2 gene expression is induced by oxidized LDL ( OxLDL) in human macrophages. Because OxLDLs contain natural activators of peroxisome proliferator-activated receptor alpha (PPAR alpha),a fatty acid-activated nuclear receptor, the regulation of NPC1 and NPC2 by PPAR alpha and the consequences on cholesterol trafficking were further studied. NPC1 and NPC2 expression is induced by synthetic PPAR alpha ligands in human macrophages. Furthermore, PPAR alpha activation leads to an enrichment of cholesterol in the plasma membrane. By contrast, incubation with progesterone, which blocks postlysosomal cholesterol trafficking, as well as NPC1 and NPC2 mRNA depletion using small interfering RNA, abolished ABCA1-dependent cholesterol efflux induced by PPAR alpha activators. These observations identify a novel regulatory role for PPAR alpha in the control of cholesterol availability for efflux that, associated with its ability to inhibit cholesterol esterification and to stimulate ABCA1 and scavenger receptor class B type I expression, may contribute to the stimulation of reverse cholesterol transport.
引用
收藏
页码:2717 / 2725
页数:9
相关论文
共 50 条
  • [1] Peroxisome proliferator-activated receptor α reduces cholesterol esterification in macrophages
    Chinetti, G
    Lestavel, S
    Fruchart, JC
    Clavey, V
    Staels, B
    CIRCULATION RESEARCH, 2003, 92 (02) : 212 - 217
  • [2] Effect of peroxisome proliferator-activated receptor γ on the cholesterol efflux of peritoneal macrophages in inflammation
    He, Kun
    Li, Yue
    Yang, Kang
    Gong, Jian-Ping
    Li, Pei-Zhi
    MOLECULAR MEDICINE REPORTS, 2014, 10 (01) : 373 - 378
  • [3] Peroxisome proliferator-activated receptor γ and atherosclerosis
    Marx, N
    CURRENT HYPERTENSION REPORTS, 2002, 4 (01) : 71 - 77
  • [4] Visfatin is induced by peroxisome proliferator-activated receptor gamma in human macrophages
    Mayi, Therese Hervee
    Duhem, Christian
    Copin, Corinne
    Bouhlel, Mohamed Amine
    Rigamonti, Elena
    Pattou, Francois
    Staels, Bart
    Chinetti-Gbaguidi, Giulia
    FEBS JOURNAL, 2010, 277 (16) : 3308 - 3320
  • [5] Peroxisome proliferator-activated receptor agonists
    Willson, TM
    Wahli, W
    CURRENT OPINION IN CHEMICAL BIOLOGY, 1997, 1 (02) : 235 - 241
  • [6] Peroxisome proliferator-activated receptor δ controls muscle development and oxydative capability
    Luquet, S
    Lopez-Soriano, J
    Holst, D
    Fredenrich, A
    Melki, J
    Rassoulzadegan, M
    Grimaldi, PA
    FASEB JOURNAL, 2003, 17 (13): : 2299 - +
  • [7] Peroxisome proliferator-activated receptor γ and cancers
    Koeffler, HP
    CLINICAL CANCER RESEARCH, 2003, 9 (01) : 1 - 9
  • [8] The peroxisome proliferator-activated receptor δ promotes lipid accumulation in human macrophages
    Vosper, H
    Patel, L
    Graham, TL
    Khoudoli, GA
    Hill, A
    Macphee, CH
    Pinto, I
    Smith, SA
    Suckling, KE
    Wolf, CR
    Palmer, CNA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (47) : 44258 - 44265
  • [9] Antiinflammatory roles of peroxisome proliferator-activated receptor γ in human alveolar macrophages
    Asada, K
    Sasaki, S
    Suda, T
    Chida, K
    Nakamura, H
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (02) : 195 - 200
  • [10] Chondrosarcoma and Peroxisome Proliferator-Activated Receptor
    Nishida, K.
    Kunisada, T.
    Shen, Z. N.
    Kadota, Y.
    Hashizume, K.
    Ozaki, T.
    PPAR RESEARCH, 2008, 2008